Reata Pharmaceuticals Inc (NASDAQ:RETA)
| 90.01 BATS BZX Real-Time Price As of 3:59pm ET |  +2.49 / +2.85%Today’s Change | 18.47 Today|||52-Week Range 95.00 | +136.93% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 42.0M | 84.7M | 129.8M | 337.8M | |
| Short Term Investment Cash | -45.8M | 42.7M | 45.0M | 208.0M | ||
| Cash & Short Term Investments | 42.0M | 84.7M | 129.8M | 337.8M | ||
| Receivables | Receivables | 31.9M | 0.00 | 0.00 | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 3.3M | 2.6M | 3.3M | 4.5M | |
| Current Assets | 77.3M | 87.3M | 133.1M | 342.3M | ||
| Total Assets | Property, Plant and Equipment - Gross | 14.1M | 14.0M | 13.0M | 14.2M | |
| Depreciation | -13.0M | -13.2M | -12.3M | -12.7M | ||
| Other Assets | 553.0K | 991.0K | 1.5M | 1.5M | ||
| Total Assets | 79.0M | 89.1M | 135.3M | 345.2M | ||
| Liabilities | Accounts Payable | 3.5M | 3.8M | 2.1M | 4.5M | |
| Short Term Debt | 0.00 | 0.00 | 1.2M | 0.00 | ||
| Accrued Expenses | 3.5M | 6.2M | 12.6M | 15.4M | ||
| Other Current Liabilities | 57.3M | 55.8M | 44.3M | 51.4M | ||
| Other Liabilities | 60.8M | 59.6M | 47.6M | 55.9M | ||
| Total Liabilities | Long Term Debt | 0.00 | 0.00 | 18.4M | 79.2M | |
| Other Liabilities | 249.0K | 72.0K | 53.0K | 524.0K | ||
| Total Liabilities | 352.1M | 304.1M | 282.3M | 330.0M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | -- | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | -273.1M | -215.0M | -147.0M | 15.2M | ||
| Total Shareholder Equity | -273.1M | -215.0M | -147.0M | 15.2M | ||
| Share Information | Common Shares Outstanding | 22.3M | 22.3M | 26.1M | 29.7M | |
| Addtl. Info. | No data currently available for this section. | |||||
